Abbott Laboratories has been reinstated to membership of the Association of the British Pharmaceutical Industry (ABPI) following the company's suspension at the start of the year. The ABPI Board of Management has noted that the importance of complying with the ABPI Code of Practice has been made clear to all Abbott staff, and an audit report in May referred to the company's commitment to compliance and its progress in recent months.
13 Jul 2006 Posted in News Release By Press Office
The ABPI Board decided that Abbott should be reinstated to membership with effect from July 1, but that there should be a further audit within six months to ensure progress is being maintained.
Abbott Laboratories was suspended from membership for a minimum of six months after it was found to be in breach of the code, including Clause 2 which deals with activities that bring discredit on, or reduce confidence in, the pharmaceutical industry